Antibiotic susceptibility pattern of rapidly growing mycobacteria

Journal of Postgraduate Medicine
R GayathriH N Madhavan

Abstract

The rapidly growing mycobacteria (RGM) causing human infections primarily consist of the Mycobacterium fortuitum group, Mycobacterium abscessus and Mycobacterium chelonae. The antibiotic susceptibility testing is important to determine the appropriate therapy as the antibiotics used to treat RGM are different from those used for treating infections caused by slow growers of mycobacteria. To determine antibiotic susceptibility of RGM using Kirby Bauer method and following Clinical and Laboratory Standards Institute (CLSI) guidelines. Larsen and Toubro Microbiology Research Centre, Vision Research Foundation, Sankara Nethralaya, Chennai, Retrospective study. The antibiotic susceptibility testing was performed following CLSI method for the drugs Amikacin, Azithromycin, Tobramycin, Ceftazidime, Cephotaxime, Cefuroxime, Cefaperazone, Ceftriaxone, Ciprofloxacin, Ofloxacin, Norfloxacin, Gatifloxacin and Moxifloxacin. Out of the 148 RGM isolates 146 (98%) were susceptible to amikacin, 138 (91%) to gatifloxacin, 132 (87%) to moxifloxacin, 122 (76%) to ciprofloxacin and 116 (74%) to Norfloxacin. Majority of the RGM were resistant to Ceftazidime, Cephotaxime and Cefaperazone. All the M. abscessus isolates were resistant to tobramycin. The...Continue Reading

References

Oct 1, 1990·The American Review of Respiratory Disease
Aug 1, 1982·Antimicrobial Agents and Chemotherapy·J M SwensonV A Silcox
Dec 20, 1999·The Journal of Antimicrobial Chemotherapy·S VacherJ Maugein
Oct 19, 2000·Antimicrobial Agents and Chemotherapy·A AubryE Cambau
Oct 30, 2001·Journal of Clinical Microbiology·M A YakrusB Metchock
Oct 5, 2002·Clinical Microbiology Reviews·Barbara A Brown-Elliott, Richard J Wallace
May 23, 2003·Antimicrobial Agents and Chemotherapy·Shun-Cheng YangKwen-Tay Luh
Feb 28, 2008·Journal of Korean Medical Science·Sunghoon ParkWon-Jung Koh

❮ Previous
Next ❯

Citations

Apr 1, 2013·Journal of Research in Pharmacy Practice·Shamungum SriramThekkinkattil Mohankumar
Dec 3, 2011·Enfermedades infecciosas y microbiología clínica·Pedro García-Martos, Lidia García-Agudo
Aug 15, 2013·Journal of Cardiac Surgery·Shinya UnaiHitoshi Hirose
Oct 16, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Parvin HeidariehAbodolrazagh Hashemi Shahraki
Mar 31, 2015·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I B RamisA Martin
May 21, 2011·European Annals of Otorhinolaryngology, Head and Neck Diseases·D-Q NguyenS Schmerber
May 14, 2016·Journal of Clinical Laboratory Analysis·Natalia Fernandes Garcia de CarvalhoErica Chimara
Jun 3, 2014·Expert Review of Respiratory Medicine·Valerie Waters, Felix Ratjen
Aug 9, 2011·The Journal of International Medical Research·P ZhaoK L Wan
Mar 21, 2017·International Journal of Mycobacteriology·Roumi GhoshPrasanta Kumar Maiti
Jan 1, 2013·Infectious Diseases·Balkis A TalipWilliam J Snelling
Dec 22, 2016·The Cochrane Database of Systematic Reviews·Valerie Waters, Felix Ratjen
Jun 11, 2020·The Cochrane Database of Systematic Reviews·Valerie Waters, Felix Ratjen
Aug 31, 2020·International Journal of Mycobacteriology·Waniganeththi Arachchige Manori Piyumal SamaranayakeBen Jacobus Marais
Jun 8, 2019·Jornal brasileiro de nefrologia : ʹorgão oficial de Sociedades Brasileira e Latino-Americana de Nefrologia·Jadson Soares LaudelinoVitorino Modesto Santos
Nov 11, 2015·Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases·Akira YoshimotoKeiichi Mikasa
Sep 20, 2017·The Journal of Antimicrobial Chemotherapy·Devyani DeshpandeTawanda Gumbo
Nov 29, 2011·Indian Journal of Medical Microbiology·R Set, J Shastri
May 27, 2021·Journal of Clinical Tuberculosis and Other Mycobacterial Diseases·Kelly M PenningtonZelalem Temesgen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Miki NagaoSatoshi Ichiyama
Antimicrobial Agents and Chemotherapy
A AubryE Cambau
© 2021 Meta ULC. All rights reserved